Financials
- Market Capitalization 8.54 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.21
Rapporto prezzo/fatturato
16.08
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 995 | ABVX Abivax SA - American Depositary Shares | 113.37 USD | -0.81% | -1.37% | -9.23% | +38.26% | 8.90 B USD | ||
| 1009 | IMVT Immunovant, Inc. - Common Stock | 41.78 USD | -4.66% | -5.77% | +7.18% | +117.49% | 8.63 B USD | ||
| 1022 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.96 USD | 0.00% | +0.15% | +0.60% | +151.84% | 8.39 B USD | ||
| 1031 | TGTX TG Therapeutics, Inc. - Common Stock | 54.29 USD | -2.57% | -2.57% | -1.06% | +87.08% | 8.31 B USD |